SCHEMBL3362673

SCHEMBL3362673

O=C(c1cccc(Cl)c1)C(Br)Br

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.57
GSK3B P49841 2/20 0.56
SLC6A2 P23975 5/20 0.54
SLC6A3 Q01959 4/20 0.54
CHRNA1 P02708 2/20 0.54
CHRNG P07510 2/20 0.54
CHRNB1 P11230 2/20 0.54
CHRNB2 P17787 2/20 0.54
CHRNB4 P30926 2/20 0.54
SLC6A4 P31645 2/20 0.54
CHRNA3 P32297 2/20 0.54
CHRNA4 P43681 2/20 0.54
CHRND Q07001 2/20 0.54
ITGA5 P08648 1/20 0.54
CYP2C19 P33261 1/20 0.54
HRH1 P35367 1/20 0.54
CHRNA7 P36544 1/20 0.54
OPRK1 P41145 1/20 0.54
KCNH2 Q12809 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28473881 0.86 PARP1 (0.55) PARP1GSK3BSLC6A2SLC6A3CHRNA1
SCHEMBL10898106 0.86 PARP1 (0.55) PARP1GSK3BSLC6A2SLC6A3CHRNA1
SCHEMBL29848174 0.85 SLC6A2 (0.59) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL633225 0.85 SLC6A2 (0.59) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL8639727 0.85 PARP1 (0.53) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL5256414 0.82 SLC6A2 (0.61) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL4741238 0.82 PARP1 (0.50) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL5370186 0.82 GSK3B (0.50) PARP1GSK3BSLC6A2SLC6A3CHRNA1
SCHEMBL28631032 0.82 PARP1 (0.50) PARP1SLC6A2SLC6A3CHRNA1CHRNG
SCHEMBL8867285 0.82 PARP1 (0.59) PARP1SLC6A2SLC6A3CHRNA1CHRNG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109912434-A The synthetic method of phenyl ethyl amine beta receptor agonist 上海安谱实验科技股份有限公司 2019-06-21 CN disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed
CN-1867571-A In situ preparation of chiral derivatives of oxaborolidine-borane complexes, useful in asymmetric reduction reactions of etheroximes or ketones to chiral alcohols or amines PPG SIPSY (FR) 2006-11-22 CN disclosed
EP-1673375-A2 METHOD FOR THE IN SITU PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM OXAZABOROLIDINE-BORANE COMPLEXES, WHICH ARE USED IN ASYMMETRIC REDUCTION REACTIONS PPG-Sipsy (FR) 2006-06-28 EP disclosed
WO-2005035540-A2 METHOD FOR THE IN SITU PREPARATION OF CHIRAL COMPOUNDS DERIVED FROM OXAZABOROLIDINE-BORANE COMPLEXES, WHICH ARE USED IN ASYMMETRIC REDUCTION REACTIONS PPG-SIPSY (FR) 2005-04-21 WO disclosed